Who Paid My Doc
Reveal LINQ
Device Cardiac Diagnostics and Monitoring
PDI 00643169845749
General payments
$296,433
Research payments
$17,087,254
Through program year 2025, $296,433 in general payments and $17,087,254 in research payments were reported against Reveal LINQ (Cardiac Diagnostics and Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $17,163 | 503 |
| 2025 | Research | $3,097,863 | 460 |
| 2024 | General | $30,011 | 609 |
| 2024 | Research | $4,856,900 | 632 |
| 2023 | General | $46,423 | 1,068 |
| 2023 | Research | $4,453,142 | 845 |
| 2022 | General | $70,673 | 1,545 |
| 2022 | Research | $2,693,644 | 699 |
| 2021 | General | $132,164 | 3,573 |
| 2021 | Research | $1,985,706 | 499 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,298 general · 3,135 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.